PharmacoEthics Articles

An EthicsWeb website

Contact Information:

This site is owned by:
Chris MacDonald ()

Ashley Pringle

Ethical Issues in Pharmaceutical Drug Pricing

[Draft] Bibliography (1992-2004) by Trevor Coffrin

(under supervision of Dr. Chris MacDonald)

  • Angell, Marcia. The Truth About the Drug Companies. (New York: Random House, 2004).

  • Balasubramaniam, K. “Improving access to essential drugs for people living with HIV/AIDS,” Indian Journal of Medical Ethics. Available on-line at:

  • Brody, Baruch, A. Ethical Issues in Drug Testing, Approval, and Pricing. (New York: Oxford University Press, 1995).

  • Calfee, John E. “Pharmaceutical Price Controls and Patient Welfare,” Annals of Internal Medicine 2001, 134(11): 1060-1064, as appears at:

  • Carey, John, “What's a Fair Price for Drugs?” Business Week, April 30, 2001. p. 105.

  • Chumney,  E.C.G. & Simpson, K. N. “The emerging role of the consumer in pharmaceutical pricing decisions,” Disease Management & Health Outcomes 2002, 10 (4): p. 229-232.

  • Davidoff, Frank. “The heartbreak of drug pricing” Annals of Internal Medicine 2001, 134 (11): p. 1071, as appears at:

  • Dowell, William. “Ethics and AIDS drugs,” Time. New York: July 12, 1999, 154 (2):  p. 49.

  • “Ethics Cannot Justify Fixing The Highest Prices For Medicines,” from

  • GlaxoSmithKline “Facing The Challenge.” 2004. Available on-line at:

  • Hammer, Peter, J. “Differential pricing of essential aids drugs,” Journal of International Economic Law. Oxford: December 2002, 5 (4): p. 883.

  • Haugh, Richard. “Getting the attention of big pharma,” Hospitals & Health Networks. Chicago: October 2003, 77 (10):  p. 44.

  • “Investors asked to assess firms on ethics,” (Manifest monthly newsletter, September 2002), available at:

  • Light, Donald & Lexchin, Joel, “Will Lower Drug Prices Jeopardize Drug Research? A Policy Fact Sheet.” The American Journal of Bioethics 2004, 4(1): W1-W4. Available on-line at:

  • Mahan, Dee. “Profiting from Pain: Where Prescription Drug Dollars go,” from

  • Maitland, Ian. “Priceless goods: How should life-saving drugs be priced?” Business Ethics Quarterly. Chicago, October 2002, 12 (4): p. 451.

  • Nakagawa, Bob. “More the Same Than Different,” Journal of Ambulatory Care Management, July-September 2004, 27 (3): p. 194-202.

  • Oxfam, Save the Children, and VSO, “Beyond Philanthropy: the pharmaceutical industry, corporate social responsibility and the developing world,” 2002. Available on-line at:

  • Plitch, Phyllis. “Religious Groups Invoke Holding Power To Press Drug Makers to Rein in Prices,” Wall Street Journal (Eastern edition) New York, N.Y. February 7, 2000. p. 1.

  • Public Citizens Congress Watch, “Pharmaceuticals rank as most Profitable Industry, Again.” April 17th, 2002. Available on-line at:

  • Pujari, Sanjay. “Antiretroviles in India,” Indian Journal of Medical Ethics available on-line at:

  • Roberts, Mark J. “Notes on the Ethics of Drug Pricing,” from

  • Rosin, Leah J. “Are pharmaceutical prices just? A discussion of business, values, and ethics” Available on-line at:

  • Schüklenk, Udo & Ashcroft, Richard E. Affordable Access to Essential Medication in Developing Countries,” Journal of Medicine and Philosophy. April 2002, 27 (2): p.179-196.

  • Spinello, Richard, A. “Ethics, Pricing and the Pharmaceutical Industry,” Journal of Business Ethics August 1992, 11 (8): p. 617-627.

  • “Swiss-pharma-AIDS-ethics,” Agence France-Presse. February 3, 2003. Available on-line at:

  • White, Ronald, F. & Fraley, Sean. “Imperfect Competition, Price-Fairness, and the Pharmaceutical Industry.” Available on-line at:

  • Wechsler, J. “Key issues emerge surrounding pharmaceutical pricing,” Formulary July 2004, 39 (7): p. 370-371.

  • Xia, Lan; Monroe, Kent, B; Cox, Jennifer, L. “The Price Is Unfair! A Conceptual Framework of Price Fairness Perceptions,” Journal of Marketing. Chicago: October 2004, 68 (4): p. 1.


For ethics books, see...